Apexium Financial LP Has $1.50 Million Stock Position in UnitedHealth Group Incorporated $UNH

Apexium Financial LP decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,816 shares of the healthcare conglomerate’s stock after selling 219 shares during the quarter. Apexium Financial LP’s holdings in UnitedHealth Group were worth $1,502,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Future Financial Wealth Managment LLC boosted its position in shares of UnitedHealth Group by 164.9% during the 2nd quarter. Future Financial Wealth Managment LLC now owns 1,486 shares of the healthcare conglomerate’s stock worth $464,000 after acquiring an additional 925 shares in the last quarter. Hennessy Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $109,000. Ameriflex Group Inc. raised its holdings in shares of UnitedHealth Group by 5.0% during the 2nd quarter. Ameriflex Group Inc. now owns 1,938 shares of the healthcare conglomerate’s stock worth $587,000 after buying an additional 92 shares in the last quarter. ZWJ Investment Counsel Inc. boosted its stake in UnitedHealth Group by 1.8% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,270 shares of the healthcare conglomerate’s stock valued at $1,020,000 after buying an additional 59 shares in the last quarter. Finally, Successful Portfolios LLC grew its position in UnitedHealth Group by 19.7% in the second quarter. Successful Portfolios LLC now owns 1,311 shares of the healthcare conglomerate’s stock valued at $409,000 after acquiring an additional 216 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $360.17 on Friday. The business’s 50 day simple moving average is $307.84 and its 200 day simple moving average is $355.58. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a market capitalization of $326.20 billion, a PE ratio of 15.61, a PEG ratio of 2.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 earnings per share. The business’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Sanford C. Bernstein lifted their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Bank of America lifted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research report on Monday, August 18th. Finally, KeyCorp reduced their price target on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.